Account-Based Marketing for HealthTech at Public Company
A step-by-step playbook for implementing account based marketing at a Public Company-stage HealthTech company. This guide covers everything from initial setup and team requirements to execution, measurement, and optimization — tailored specifically for HealthTech companies with publicly accountable marketing budget tied to quarterly targets and large, specialized teams with institutional processes. Includes specific KPIs, recommended tools, common pitfalls to avoid, and expert insights from Ehsan Jahandarpour.
Timeline: 1-2 months
Prerequisites
- ✓ Established product with proven product-market fit
- ✓ Analytics infrastructure capturing key user events
- ✓ HIPAA, FDA, and healthcare-specific regulations require specialized compliance infrastructure — ensure compliance before scaling
- ✓ CRM with clean account data
- ✓ Sales team aligned on target account criteria
Step-by-Step Guide
Build your ideal customer profile (ICP)
Define your target accounts using firmographic data (industry, size, tech stack, funding) and behavioral signals (hiring patterns, content engagement). For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: Start with your best 10 current customers and reverse-engineer what they have in common. In the HealthTech context, also consider: HIPAA compliance complexity.
Build a target account list
Create a tiered list of target accounts: Tier 1 (10-25 accounts, fully personalized), Tier 2 (50-100, semi-personalized), Tier 3 (200-500, programmatic). For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: Use tools like ZoomInfo, Apollo, or LinkedIn Sales Navigator to enrich your list. In the HealthTech context, also consider: slow adoption by medical professionals.
Map buying committees
Identify 3-7 stakeholders per target account: economic buyer, champion, technical evaluator, end user, and blocker. Create personalized messaging for each role. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: The champion is the most important person — they sell internally when you are not in the room. In the HealthTech context, also consider: long procurement cycles.
Create personalized content and ads
Develop account-specific landing pages, case studies, and ad creative. Use dynamic content to reference the target company name and industry challenges. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: One deeply personalized email beats 100 generic ones. Mention specific company initiatives or challenges. In the HealthTech context, also consider: clinical validation requirements.
Orchestrate multi-channel outreach
Coordinate touchpoints across email, LinkedIn, display ads, direct mail, and events. Each touchpoint should build on the last. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: Use a 21-day cadence: email day 1, LinkedIn day 3, ad impression day 5, follow-up email day 7. In the HealthTech context, also consider: HIPAA compliance complexity.
Measure account engagement and pipeline
Track account-level engagement scores, not just individual lead metrics. Measure influenced pipeline, deal velocity, and win rates for ABM vs non-ABM deals. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: ABM is a long game — measure engagement trends over quarters, not days. In the HealthTech context, also consider: slow adoption by medical professionals.
Expected Outcomes
- ✓ 40-60% engagement rate from target HealthTech accounts
- ✓ 2-3x higher deal size for ABM-targeted accounts
- ✓ 25-35% faster sales cycle for accounts with multi-threaded engagement
- ✓ ABM-influenced pipeline accounting for 30-50% of total pipeline
KPIs to Track
- ● Win rate for ABM vs non-ABM
- ● Cost per target account acquired
- ● Target account engagement score
- ● ABM-influenced pipeline
Common Mistakes to Avoid
Ehsan's Growth Commentary
HealthTech ABM is mandatory because the buyer universe is small and concentrated: there are ~6,000 hospitals in the US, and the top 200 health systems control 50%+ of beds. Every enterprise healthtech company is running ABM against the same 200 targets. The healthtech ABM differentiation: clinical evidence. While competitors send generic case studies, the most effective healthtech ABM delivers account-specific clinical projections. "Based on your hospital's patient volume and case mix, our AI would have flagged 47 additional cases last quarter that matched clinical trial criteria, representing $2.3M in potential trial revenue." This level of specificity requires analyzing publicly available hospital data (CMS quality reports, HCAHPS scores, case mix indices) and modeling your product's impact on that specific hospital. The effort is significant (2-4 hours per target account) but the conversion rate for account-specific clinical projections is 3-5x higher than generic ABM.
ABM is a team sport. If sales and marketing are not meeting weekly to review target account engagement, it is not ABM. In HealthTech, the buying committee typically has 5-7 stakeholders. Map all of them before your first outreach. Personalized direct mail still works. A $50 gift with a personal note outperforms $5,000 in digital ads for enterprise deals.
Ehsan Jahandarpour
AI Growth Strategist & Fractional CMO
Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations · Ex-Microsoft · CMO at FirstWave (ASX:FCT) · Forbes Communications Council